Comparison of 3-to 6-month versus 12-month dual antiplatelet therapy after coronary intervention using the contemporary drug-eluting stents with ultrathin struts: the …
Background: Limited data are available on short-term dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention using third-generation drug-eluting stents with ultrathin …
percutaneous coronary intervention using third-generation drug-eluting stents with ultrathin …
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta …
S Benenati, M Galli, V De Marzo… - European Heart …, 2021 - academic.oup.com
Aim To provide an updated assessment of the efficacy–safety profile of very short (1 or 3
months) dual antiplatelet therapy (DAPT) compared with long (12 months) DAPT in patients …
months) dual antiplatelet therapy (DAPT) compared with long (12 months) DAPT in patients …
Safety of an abbreviated duration of dual antiplatelet therapy (≤ 6 months) following second‐generation drug‐eluting stents for coronary artery disease: a systematic …
KM Ziada, A Abdel‐Latif, R Charnigo… - Catheterization and …, 2016 - Wiley Online Library
Background Dual antiplatelet therapy (DAPT) is recommended for≥ 12 months following
coronary drug‐eluting stents (DES) to reduce risk of major adverse ischemic events …
coronary drug‐eluting stents (DES) to reduce risk of major adverse ischemic events …
Meta-analysis of the duration of dual antiplatelet therapy in patients treated with second-generation drug-eluting stents
The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention, especially in the era of second-generation …
(DAPT) after percutaneous coronary intervention, especially in the era of second-generation …
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second …
D Giacoppo, Y Matsuda, LN Fovino… - European heart …, 2021 - academic.oup.com
Aims After percutaneous coronary intervention (PCI) with second-generation drug-eluting
stent (DES), whether short dual antiplatelet therapy (DAPT) followed by single antiplatelet …
stent (DES), whether short dual antiplatelet therapy (DAPT) followed by single antiplatelet …
Safety of short-term dual antiplatelet therapy after drug-eluting stents: an updated meta-analysis with direct and adjusted indirect comparison of randomized control …
Background Duration of dual antiplatelet therapy (DAPT) following drug-eluting stents (DES)
remains controversial and is a topic of ongoing research. Methods Direct and adjusted …
remains controversial and is a topic of ongoing research. Methods Direct and adjusted …
Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis
Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After …
Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents
G El-Hayek, F Messerli, S Bangalore, MK Hong… - The American journal of …, 2014 - Elsevier
Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) after drug-
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
Objective To evaluate the efficacy and safety of standard term (12 months) or long term (> 12
months) dual antiplatelet therapy (DAPT) versus short term (< 6 months) DAPT after …
months) dual antiplatelet therapy (DAPT) versus short term (< 6 months) DAPT after …